A single-amino-acid substitution in Obg activates a new programmed cell death pathway in Escherichia coli by Dewachter, Liselot et al.
1 
 
A single amino acid substitution in Obg activates a new programmed cell death pathway in 1 
Escherichia coli 2 
 3 
Authors 4 
Liselot Dewachtera, Natalie Verstraetena, Daniel Monteyneb, Cyrielle Ines Kinta, Wim Verséesc,d, 5 
David Pérez-Morgab,e, Jan Michielsa*, Maarten Fauvarta 6 
Author Affiliations 7 
aCentre of Microbial and Plant Genetics, KU Leuven - University of Leuven, 3001 Leuven, 8 
Belgium. 9 
bLaboratory of Molecular Parasitology, Institut de Biologie et de Médecine Moléculaires (IBMM), 10 
Université Libre de Bruxelles, 6041 Gosselies, Belgium. 11 
cStructural Biology Brussels, Vrije Universiteit Brussel, 1050 Brussels, Belgium. 12 
dStructural Biology Research Center, VIB, 1050 Brussels, Belgium. 13 
eCenter for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles, 6041 14 
Gosselies, Belgium. 15 
*Address correspondence to Jan Michiels, Jan.Michiels@biw.kuleuven.be  16 
J.M. and M.F. are joint senior authors. 17 
 18 
Word count abstract: 173 19 
Word count importance: 150 20 
Word count main text: 2510 21 
  22 
2 
 
ABSTRACT 23 
Programmed cell death (PCD) is an important hallmark of multicellular organisms. Cells self-24 
destruct through a regulated series of events for the benefit of the organism as a whole. The 25 
existence of PCD in bacteria has long been controversial due to the widely held belief that only 26 
multicellular organisms would profit from this kind of altruistic behavior at the cellular level. 27 
However, over the past decade, compelling experimental evidence has established the existence of 28 
such pathways in bacteria. Here, we report that expression of a mutant isoform of the essential 29 
GTPase ObgE causes rapid loss of viability in Escherichia coli. The physiological changes that 30 
occur upon expression of this mutant protein – including loss of membrane potential, chromosome 31 
condensation and fragmentation, exposure of phosphatidylserine on the cell surface and membrane 32 
blebbing – point to a PCD mechanism. Importantly, key regulators and executioners of known 33 
bacterial PCD pathways were shown not to influence this cell death program. Collectively, our 34 
results suggest that the cell death pathway described in this work constitutes a new mode of 35 
bacterial PCD.  36 
 37 
IMPORTANCE 38 
Programmed cell death (PCD) is a well-known and important phenomenon in higher eukaryotes. 39 
In these organisms PCD is essential for embryonic development – for example the disappearance 40 
of the interdigital web – and also functions in tissue homeostasis and elimination of pathogen-41 
invaded cells. The existence of PCD mechanisms in unicellular organisms like bacteria, on the 42 
other hand, has only recently begun to be recognized. We here demonstrate the existence of a 43 
bacterial PCD pathway that induces characteristics that are strikingly reminiscent of eukaryotic 44 
apoptosis, such as fragmentation of DNA, exposure of phosphatidylserine on the cell surface and 45 
membrane blebbing. Our results can provide more insight into the mechanism and evolution of 46 
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PCD pathways in higher eukaryotes. More importantly, especially in the light of the looming 47 
antibiotic crisis, they may point to a bacterial Achilles heel and can inspire innovative ways of 48 
combatting bacterial infections, directed at the targeted activation of PCD pathways. 49 
 50 
MAIN TEXT 51 
The term programmed cell death (PCD) is used for all genetically encoded pathways resulting in 52 
the cell’s demise. Although many different types of PCD exist, it is best known under the form of 53 
apoptosis. Apoptosis is a process present in multicellular eukaryotic organisms, which is involved 54 
in embryogenesis, maintenance of tissue homeostasis and elimination of potentially dangerous 55 
cells (1, 2). This type of cell death is associated with many physiological changes including 56 
chromatin condensation, DNA fragmentation, exposure of phosphatidylserine on the cell surface 57 
and plasma membrane blebbing (1-3). Other PCD mechanisms present in metazoans include 58 
autophagy and programmed necrosis (3). 59 
Although PCD pathways provide a clear benefit to the survival and development of multicellular 60 
organisms, the existence of such pathways is not restricted to higher eukaryotes. PCD is present in 61 
unicellular eukaryotes (4, 5) as well as in bacteria (6-11).  62 
While the existence of PCD in bacteria might seem counter-intuitive, it has long been known that 63 
these pathways function in developmental programs like fruiting body formation of Myxococcus 64 
xanthus and sporulation of Bacillus subtilis (12). More recently, a particular PCD pathway of 65 
Staphylococcus aureus was also shown to play a role in biofilm development (9). Moreover, it was 66 
argued that bacterial PCD might also function as an altruistic mechanism promoting the survival 67 
of the bacterial population during stressful conditions such as nutrient limitation and phage 68 
infection (12, 13). If true, bacterial PCD – as is the case for eukaryotic PCD mechanisms – 69 
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functions in both the development of multicellular structures and the prolonged preservation of the 70 
‘organism’, the bacterial population. 71 
We here report on a new bacterial PCD pathway in Escherichia coli. This pathway is triggered by 72 
the expression of a mutant isoform of the essential GTPase ObgE (Obg of E. coli). This mutant 73 
isoform carries a single amino acid substitution, K268I, located in the GTPase domain. 74 
Biosynthesis of ObgEK268I (further denoted as ObgE*) rapidly elicits cell death and is associated 75 
with physiological changes that are markers of PCD. These physiological changes include loss of 76 
membrane potential, chromosome condensation, DNA fragmentation, exposure of 77 
phosphatidylserine on the cell surface and membrane blebbing. We demonstrate that ObgE* 78 
triggers a PCD pathway that differs fundamentally from other previously described bacterial PCD 79 
mechanisms. 80 
 81 
ObgE*-mediated cell death. 82 
We previously explored the role of specific amino acid residues of ObgE in sensitivity towards 83 
hydroxyurea by screening a mutant obgE overexpression library constructed by error-prone PCR 84 
(14). Controlled expression of one of the mutant alleles, encoding ObgEK268I (ObgE*), rapidly leads 85 
to cell death and is the focus of the current study.  86 
Cell death caused by ObgE* was investigated by determining the number of colony forming units 87 
(CFUs) per mL at different time points before and after induction of protein expression (Fig. 1A). 88 
ObgE* causes a decrease in the number of CFUs per mL of more than 4 orders of magnitude and 89 
this in less than 40 minutes after induction of expression. To confirm that ObgE* causes cell death 90 
rather than a switch to a non-growing state, cells expressing ObgE* were subjected to Live/Dead 91 
staining. The result of this staining confirms that ObgE* is bactericidal and leads to eventual loss 92 
of membrane integrity (data not shown). These experiments were carried out in an E. coli strain 93 
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that retains the chromosomal obgE gene. We therefore conclude that obgE* is a dominant negative 94 
allele which – when expressed – causes rapid cell death in E. coli. 95 
 96 
ObgE* triggers a PCD mechanism. 97 
To demonstrate that the cell death mechanism triggered by ObgE* is programmed, a wide array of 98 
PCD markers was investigated. The investigated markers are loss of membrane potential, 99 
chromosome condensation, DNA fragmentation, phosphatidylserine exposure and membrane 100 
blebbing. 101 
It was previously shown that bacterial PCD is associated with a loss of membrane potential (7, 8). 102 
Similarly, depolarization of the mitochondrial inner membrane is also a key characteristic of the 103 
intrinsic pathway of eukaryotic apoptosis (2). By using the potential-sensitive DiBAC4(3) dye, we 104 
found that loss of membrane potential also occurs during ObgE*-mediated cell death (Fig. 1B).  105 
A second marker of PCD, chromosome condensation, was visualized using the blue DNA stain, 106 
DAPI. DAPI staining of cells expressing ObgE* shows multiple condensed foci of DNA per cell, 107 
whereas the DNA of cells containing the empty vector or cells expressing ObgE occupies the entire 108 
cell volume (Fig. 1C). In these experiments, membranes were visualized by concomitant staining 109 
with the lipophilic dye FM4-64. In addition to DNA condensation, it is clear that ObgE* also causes 110 
a defect in cell division, leading to the formation of cell chains up to 10 cells long. 111 
The third marker of PCD that was detected is fragmentation of DNA, which is also a key 112 
characteristic of apoptosis. DNA fragmentation was evaluated using the TUNEL (terminal 113 
deoxynucleotidyl transferase dUTP nick end labeling) assay. This assay makes use of a terminal 114 
deoxynucleotidyl transferase that couples free 3’OH groups of DNA to a dUTP residue that is 115 
covalently coupled to fluorescein isothiocyanate (FITC), linking fluorescence to DNA damage. 116 
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Compared to cells carrying the empty vector or cells expressing wild-type ObgE, ObgE* leads to 117 
an increase in FITC-fluorescence, indicating an increase in DNA damage (Fig. 1D). 118 
Fourth, externalization of phosphatidylserine, a phospholipid that is normally localized in the inner 119 
leaflet of the cell membrane, was demonstrated using FITC-conjugated annexin V (Fig. 1E). 120 
Annexin V is a protein that specifically binds to phosphatidylserine and is excluded from cells with 121 
intact cell membranes. To discriminate between cells exposing phosphatidylserine on the cell 122 
surface and cells that have lost membrane integrity, the membrane-impermeable DNA dye 123 
propidium iodide (PI) was used. An increase in FITC-annexin V binding can be seen upon 124 
expression of ObgE*, clearly showing the externalization of phosphatidylserine during the 125 
progression of cell death. 126 
A final physiological characteristic that is associated with both apoptosis and programmed necrosis 127 
is the formation of protrusions of the membrane, called membrane blebs (2). Because of the drastic 128 
structural changes of the eukaryotic plasma membrane during PCD, the membrane structure of E. 129 
coli during ObgE*-mediated cell death was visually inspected by means of scanning electron 130 
microscopy (SEM). Images show extensive membrane blebbing when ObgE*, but not ObgE, is 131 
expressed (Fig. 1F). 132 
Combined, the loss of viability upon expression of ObgE* and the concomitant phenotypic changes 133 
that we observed (loss of membrane potential, DNA condensation and fragmentation, exposure of 134 
phosphatidylserine at the cell surface and severe membrane deformations resembling apoptotic 135 
blebs) provide convincing evidence that the pathway triggered by ObgE* is indeed a PCD pathway. 136 
 137 
ObgE*-mediated PCD is distinct from previously described bacterial cell death mechanisms. 138 
To unravel the mechanism behind ObgE*-mediated PCD, we investigated the involvement of key 139 
regulators of previously described bacterial PCD mechanisms. Because ObgE*-triggered cell death 140 
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occurs in E. coli and exhibits the main markers of eukaryotic apoptosis, the most likely candidate 141 
pathway is so-called apoptosis-like death (ALD) (7, 8). Although the molecular pathway involved 142 
in ALD has not been fully uncovered yet, it was previously shown that this pathway requires the 143 
multifunctional enzyme RecA and its role in the SOS response (7, 8). The SOS response is activated 144 
by RecA in the presence of DNA damage and leads to the expression of over 40 genes involved in 145 
DNA damage repair (8). In case of overwhelming DNA damage however, high levels of activation 146 
of the SOS response presumably lead to ALD rather than repair, thereby preventing a futile attempt 147 
to repair DNA that is beyond salvage (8). However, deletion of the recA gene did not restore 148 
viability in the presence of ObgE* (Fig. 2A) and had no effect on any of the PCD markers 149 
investigated (Fig. S1). Moreover, a β-galactosidase assay with E. coli MG1655 λsfiA::lacZ (15), in 150 
which lacZ expression is controlled by the promoter of the SOS gene sfiA (also known as sulA), 151 
showed that expression of ObgE* does not result in activation of the SOS response (Fig. 2B), 152 
although this strain is also sensitive to ObgE* expression (data not shown). 153 
Another PCD pathway described in E. coli is mediated by the type II toxin-antitoxin (TA) module 154 
MazEF (6). The E. coli strain used in the current study is defective in the production of the 155 
extracellular death factor (EDF) – a quorum sensing peptide that is essential for the toxic action of 156 
MazF – indicating that this pathway is not involved in ObgE*-mediated cell death. However, since 157 
a functional mazEF module is capable of preventing ALD (6, 8), ObgE*-mediated PCD was also 158 
investigated in E. coli MC4100, harboring an active EDF-mazEF pathway (6). Expression of 159 
ObgE* in E. coli MC4100 did not result in altered survival compared to E. coli MC4100 ΔmazEF 160 
(Fig. 2C). Therefore the mazEF module does not play a role in the regulation or execution of 161 
ObgE*-mediated cell death.  162 
A final bacterial PCD pathway of interest is mediated by (anti)holin-like activities and has so far 163 
only been described in Staphylococcus aureus and Pseudomonas aeruginosa (9, 16). The cidAB 164 
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and lrgAB loci are the regulators of this PCD mechanism in S. aureus. We therefore investigated a 165 
potential role for the homologous locus in E. coli, yohJK. Survival upon expression of ObgE* was 166 
assessed in the parental and single-gene knock-out strains from the Keio collection, E. coli 167 
BW25113 ΔyohJ and ΔyohK (17) (Fig 2.D). Deletion of yohJ or yohK did not alter the viability in 168 
the presence of ObgE*, excluding any role for these genes in the execution of cell death and also 169 
arguing against a protective function towards ObgE* toxicity. The P. aeruginosa alpB gene that 170 
presumably functions as a holin contributing to PCD does not have a homologue in E. coli. 171 
Other bacterial PCD pathways have either previously been shown not to be active in E. coli (10), 172 
are induced by specific triggers that do not occur during ObgE*-expression (11), or are associated 173 
with differentiation and formation of specialized structures (12) and can thus be excluded. 174 
 175 
Discussion. 176 
Serendipitous discovery of a mutant obgE allele, obgEK268I, led to the discovery of a new cell death 177 
pathway in E. coli. Cell death caused by ObgE* is associated with many markers of PCD. 178 
Importantly, ObgE*-mediated cell death does not proceed through any of the previously described 179 
bacterial PCD mechanisms, indicating that it is a fundamentally different bacterial PCD pathway. 180 
Obg proteins are P-loop GTPases that are found in all domains of life. They are involved in a 181 
myriad of important metabolic processes and are essential for bacterial viability (18, 19). Although 182 
the role of Obg in bacterial physiology is clearly invaluable, its precise functions have not been 183 
elucidated yet. A role for Obg has been described in ribosome assembly, the stringent response, 184 
DNA replication, chromosome segregation and antibiotic tolerance (18-20). It was previously 185 
suggested that Obg might function as a cell cycle checkpoint to coordinate some of these processes 186 
with cell division (18, 21).  187 
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The mechanism of ObgE*-mediated PCD is still unclear. However, considering the proposed role 188 
for ObgE as a cell cycle checkpoint, it is tempting to speculate that the K268I mutation might cause 189 
a defect in cell cycle regulation, resulting in erroneous programmed cell death. It was shown 190 
previously that both overexpression and depletion of ObgE result in filamentation (21, 22), 191 
highlighting the importance of ObgE in regulation of cell division. Eukaryotic cell cycle regulators 192 
are able to halt cell division as well as induce PCD when deemed necessary (2). The possibility 193 
that ObgE can influence both functions and that aberrant regulation of induction of cell death by 194 
ObgE* results in constitutive PCD is an intriguing hypothesis that will be investigated further. 195 
Future research will be directed into unravelling the genetic and molecular basis of ObgE*-196 
mediated PCD, the conditions that trigger it and the conservation of this cell death pathway in other 197 
organisms. This will in turn reveal the potential of this PCD pathway as a target for the future 198 
development of a new class of antibacterials. 199 
 200 
Strains, plasmids and growth conditions. 201 
In this work, E. coli WM2949 (23) with plasmid pJAT8-araE (24) was used except when stated 202 
otherwise. To investigate ObgE*-mediated effects, strains were transformed with pBAD/His A 203 
(Invitrogen), pBAD/His A-obgE (pCMPG13901) or pBAD/His A-obgE* (pCMPG13828). For all 204 
phenotypic and toxicity tests, overnight cultures were diluted 100 times in lysogeny broth (LB) 205 
containing the appropriate antibiotics, incubated for 2 hours at 37°C with continuous shaking at 206 
200 rpm and induced with 0.2 % arabinose for 2 hours under the same conditions. 207 
Toxicity tests. 208 
To characterize ObgE*-mediated toxicity (Fig. 1A), the number of CFUs per ml was determined 209 
at several time points before and after induction by plating out serial dilutions on LB containing 210 
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the appropriate antibiotics and 1.5 % agar. For all other toxicity tests, the number of CFUs per ml 211 
was determined analogously after 2 hours of induction. 212 
Membrane potential. 213 
Loss of membrane potential was determined using the membrane potential sensitive dye, 214 
DiBAC4(3) (Life Technologies), as described previously (20). Fluorescence was measured using a 215 
BD Influx cell sorter equipped with 488 nm (green) and 561 nm (red) lasers and standard filter sets. 216 
DNA fragmentation. 217 
DNA fragmentation was quantified by the TUNEL assay (APO-DIRECT kit, BD Biosciences) as 218 
described previously (7). Fluorescence was measured by means of flow cytometry. 219 
DNA condensation. 220 
For DAPI (Sigma-Aldrich) and FM4-64 (Life Technologies) staining, cultures were washed and 221 
dissolved in 10 mM MgSO4. The dyes were added simultaneously at a concentration of 10 µg/ml 222 
and cultures were incubated for 10 minutes in the dark at room temperature. Cells were visualized 223 
with the Zeiss Axio Imager Z1. Standard DAPI and Texas Red filters were used. 224 
Phosphatidylserine exposure. 225 
Exposure of phosphatidylserine at the cell surface was measured by the FITC Annexin V/Dead 226 
Cell Apoptosis Kit (Molecular Probes) as described previously (7). Fluorescence was measured by 227 
means of flow cytometry. 228 
Scanning electron microscopy. 229 
E. coli WM2949 ΔrecA samples were prepared as described above. Cultures were fixed overnight 230 
at 4°C in glutaraldehyde 2.5 % in 0.1 M cacodylate buffer (pH 7.2) and post-fixed in OsO4 2 % in 231 
the same buffer. After serial dehydration, samples were dried at critical point and coated with 232 
platinum by standard procedures. Observations were made in a Tecnai FEG ESEM QUANTA 200 233 
(FEI) and images were processed by SIS iTEM (Olympus) software. 234 
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β-galactosidase assay. 235 
To measure activation of the SOS response, cultures were induced with 0.2 % arabinose for 3 hours 236 
prior to sample collection. The β-galactosidase assay and the calculation of Miller Units as a 237 
measure of expression level were carried out as described previously (25). 238 
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FIGURE LEGENDS 315 
Figure 1: ObgE* triggers a PCD pathway. A) The number of CFUs per ml of an exponential-316 
phase culture was monitored. At time point 0, expression of ObgE or ObgE* from pBAD/His A 317 
was induced by adding 0.2 % arabinose. Error bars represent standard error of the mean. B) 318 
DiBAC4(3) staining as a measure of membrane depolarization. Fluorescence intensity was 319 
measured by flow cytometry. C) Microscopic analysis of induced cells stained with the blue DNA 320 
dye, DAPI, and the red membrane-specific dye, FM4-64. Scale bars correspond to 2 µm. D) DNA 321 
fragmentation was determined using the TUNEL assay. Percentages shown represent the fraction 322 
of the population with DNA damage. E) Staining of externalized phosphatidylserine by FITC-323 
conjugated annexin V. Percentages shown represent the fraction of the population that displays 324 
phosphatidylserine on the cell surface. Cells with compromised membrane integrity were omitted 325 
15 
 
from this figure. F) SEM images showing the formation of blebs upon ObgE* expression. Scale 326 
bars correspond to 1 µm. 327 
 328 
Figure 2: ObgE*-mediated PCD differs fundamentally from previously described bacterial 329 
PCD pathways. A) ObgE*-mediated toxicity in E. coli WM2949 pJAT8-araE and its ΔrecA 330 
derivative. B) A β-galactosidase assay with E. coli MG1655 λsfiA::lacZ shows no activation of the 331 
SOS response when ObgE* is expressed. As a positive control mitomycin C (MMC) was used at a 332 
concentration of 5 µg/ml. #p ≤ 0.05 versus empty vector control. C) ObgE*-mediated toxicity in E. 333 
coli MC4100 and its ΔmazEF derivative. D) ObgE*-mediated toxicity in E. coli BW25113 and its 334 
ΔyohJ and ΔyohK derivatives. wt = wild type, error bars represent standard error of the mean. 335 
 336 
Figure S1: ObgE* triggers PCD in a ΔrecA strain. A) DiBAC4(3) staining as a measure of 337 
membrane depolarization. Fluorescence intensity was measured by flow cytometry. B) 338 
Microscopic analysis of induced cells stained with the blue DNA dye, DAPI, and the red 339 
membrane-specific dye, FM4-64. Scale bars correspond to 2 µm. C) DNA fragmentation was 340 
determined using the TUNEL assay. Percentages shown represent the fraction of the population 341 
with DNA damage. D) Staining of externalized phosphatidylserine by FITC-conjugated annexin 342 
V. Percentages shown represent the fraction of the population that displays phosphatidylserine on 343 
the cell surface. Cells with compromised membrane integrity were omitted from this figure. 344 
